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ABSTRACT
Single-cell RNA sequencing (scRNA-seq) has revolutionized bio-
logical discovery, providing an unbiased picture of cellular hetero-
geneity in tissues. While scRNA-seq has been used extensively to
provide insight into both healthy systems and diseases, it has not
been used for disease prediction or diagnostics. Graph Attention
Networks (GAT) have proven to be versatile for a wide range of
tasks by learning from both original features and graph structures.
Here we present a graph attention model for predicting disease
state from single-cell data on a large dataset of Multiple Sclero-
sis (MS) patients. MS is a disease of the central nervous system
that can be difficult to diagnose. We train our model on single-cell
data obtained from blood and cerebrospinal fluid (CSF) for a co-
hort of seven MS patients and six healthy adults (HA), resulting
in 66,667 individual cells. We achieve 92 % accuracy in predicting
MS, outperforming other state-of-the-art methods such as a graph
convolutional network and a random forest classifier. Further, we
use the learned graph attention model to get insight into the fea-
tures (cell types and genes) that are important for this prediction.
The graph attention model also allow us to infer a new feature
space for the cells that emphasizes the differences between the two
conditions. Finally we use the attention weights to learn a new
low-dimensional embedding that can be visualized. To the best of
our knowledge, this is the first effort to use graph attention, and
deep learning in general, to predict disease state from single-cell
data. We envision applying this method to single-cell data for other
diseases.
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1 INTRODUCTION
Single cell RNA-sequencing (scRNA-seq) technology provides gene
expression data for individual cells, yielding omics-scale informa-
tion at single-cell resolution. The information contained within
transcriptomes of individual cells can be used to identify rare cells,
genes, and other changes associated with fundamental biological
processes and pathological states. However, identifying hidden
differences in cell pathophysiological trajectories is challenging.
ScRNA-seq data typically contains gene count data for more than
20, 000 transcripts across 10, 000 - 100, 000 cells and has a high-
degree of technical noise, and encompasses a large degree of bio-
logical variability [8, 24]. While these data promise to provide rich
insight into complex systems that determine health and well-being,
integrative computational tools are required to comprehensively
learn about cell states from scRNA-seq data collected across cell,
disease, and temporal modalities [41].
Computational approaches have been developed to use scRNA-
seq data to identify bio-markers for potential use in diagnostics [15],
to understand genetic factors underlying disease heterogeneity [53],
and to predict cellular response to experimental perturbations [29].
In addition, several classifiers, using primarily non-deep learning
methods, have been employed to predict cell-types from single-cell
samples [1, 55]. However, to the best of our knowledge, no computa-
tional approaches have been developed to harness scRNA-seq data
to predict disease states for the use of transcriptomic technology in
diagnosis [37]. Despite this gap, scRNA-seq data may revolution-
ize our understanding of the biological processes associated with
various disease states in addition to providing personalized insight
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into a patient’s pathophysiological state. These kinds of omics-
scale insights may be useful in tailoring treatments for personalized
medicine [22]. We propose a learning approach that harnesses the
rich-information content in a scRNA-seq dataset to characterize
and predict two pathological states related to neuroinflammation.
Multiple sclerosis (MS) is a disease of the nervous system in
which myelin, the insulating substance that surrounds nerve cell
axons, is damaged by the body’s immune system [30, 42]. This
damage causes individuals with MS to have neurological symptoms
such as difficulty with coordination, vision impairment, pain, and
fatigue, which can manifest acutely in episodic periods or lead to
progressive decline of neurological function [30]. Genome-wide
association studies have identified some genetic risk-factors associ-
ated with MS and highlighted the role of the immune system in the
disease but to the best of our knowledge, no one has used transcrip-
tomic data and modeling to study the association of transcriptomic
markers with MS [18, 36, 38]. Lack of molecular mechanistic un-
derstanding of the pathology of MS caused by an aberrant immune
system complicates the ability in diagnosing and characterizing MS;
indeed, there is no single test to diagnose MS [28]. Few molecular
MS markers are known [11]. However, current indicators of MS are
related to general neurological decline rather than the root causes
of MS [11, 28]. Given the central role of the immune system in MS,
we relied on a dataset composed of cerebrospinal fluid (CSF) and
blood, both of which contain a high-proportion of immune cells.
The selection of an immune-rich single-cell sample is critical to
identifying molecular markers that can used to predict MS disease-
state and to aid in developing a diagnostic test based on single-cell
transcriptomic technology.
The existence of disease-modifying treatments highlights the
value of this information-rich scRNA-seq data, as it can be used
to characterize personalized disease-states, which may be differen-
tially targeted with personalized treatment [28]. Current diagnoses
of MS relies on imaging, neurological symptoms observed by a
clinician and differential diagnoses, and spinal fluid abnormalities
[42]. Currently, personalized approaches using a genetic risk score,
based on genome-wide association studies, have poor agreement
with clinical and MRI measures [28, 34, 36].
Several classes of bio-molecular networks like transcriptional
regulatory networks, protein-protein interaction networks, and
metabolic networks are modeled as graphs. Mathematical graph
theory is a straightforward way to represent this information, and
graph-based models can exploit the global and local characteristics
of these networks relevant to cell biology. In recent years, Graph
Neural Networks (GNNs) have been widely adopted in various
tasks, such as graph classification [13, 26], link prediction [54] and
node classification [23, 45, 49]. Various GNNs have been proven to
be effective in achieving state-of-the-art performance in a variety of
graph datasets such as social networks [49], citation networks [45],
recommender systems [23, 49] and protein-protein interaction net-
works [45]. The underlying graph structure is utilized by GNNs to
operate convolution directly on graphs by passing node features to
neighbors [49], or to perform convolution in the spectral domain
by using the eigenbasis of the Graph Laplacian operator [23]. Since
the introduction of the self-attention mechanism in the influential
work [44], it has become extremely common to use self-attention
for various sequence-sequence tasks like machine translations and
learning representations. Self-attention allows the model to deal
with variable sized inputs and focus on the most important part of
the inputs. The self-attention mechanism has been introduced to
the graph domains by [45] and also developed by [5, 10, 52]. In our
work, we chose to utilize the Graph Attention Network (GAT) as
introduced by [45] to do node classification because of it’s high per-
formance on complex datasets, its adaptability to unseen datasets,
and the model’s interpretability. Figure 1 shows the workflow of
our paper.
Figure 1: Schematic of ourmethod depicting the use of a cell
by gene count matrix in a graph attention model to predict
and visualize disease state.
Our contributions are as follows: (i) we use graph neural net-
works on single cell data to predict disease state of MS patients
and healthy individuals, (ii) we use the attention weights matrix
to visualize the new graphs learned by the model, (iii) we extract
meaningful features from the model and investigate them in the
context of existing biological knowledge on MS.
2 DATASETS USED
We used a pooled dataset composed of blood and cerebrospinal fluid
(CSF) samples from 7 MS patients and 6 healthy adults (HA), con-
stituting 26 scRNA-seq samples with an average of 2, 500 cells per
sample and about 5, 000 cells per patient. We performed standard
scRNA-seq quality-control filtering steps to the raw data, including
removing cells expressing > 10% mitochondrial genes, normaliz-
ing gene counts by the sequenced library size per cell, square-root
transforming gene counts, and removing mitochondrial and ribo-
somal protein transcripts from downstream analysis [48]. After
the preprocessing steps our dataset is composed of 66, 667 cells
with 22, 005 gene features per cell. Figure 2(A) shows our full graph
(used in transductive task) colored by the individual patients and
figure 2(B) is colored by various cell types. Variability between
samples dominates biological variability in reduced dimensional
embeddings and these batch effects complicate model inference of
biological features [6]. We treat each cell as a node, so our dataset
has 22, 005 features per node, with high variability across features.
The number of features is an order of magnitude higher than the
citation, social-network, and protein-protein interaction datasets
previously used by GNNs. This feature matrix was used to com-
pute a k-nearest neighbor graph from euclidean distances in PCA
reduced space (10 neighbors and 100 principal components) and
clustered by the Louvain algorithm to identify cell types within
the pooled dataset [4, 32]. This led to the unsupervised identifica-
tion of at least 16 cell types within the pooled dataset, including
about 75% T cells broken into various lineages and about 15% B
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cells, in addition to other immune and peripheral blood mononu-
clear cells, including macrophages, monocytes, natural-killer cells,
and platelets. The nodes are classified as healthy or MS. Thus the
classification problem we are interested in is at the cell level.
Figure 2: Low-dimensional embeddings of single-cell data
used in this paper. A) UMAP scatter plot of the single-cell
data used for training our model colored by the 6 healthy
individuals (HA*) and 7 MS patients (MS*). Gray lines show
edges in a nearest-neighbor graph. B) UMAP scatter plot col-
ored by cell types identified in the blood and CSF.
We use this dataset to perform two tasks: (i) inductive inference,
and (ii) transductive inference. For the transduction task, we ran-
domly assign 10% of the nodes for validation and 10% for testing
while keeping the ratio of healthy and MS cells the same as in the
full dataset. Then we randomly mask the labels of 50% of the train-
ing, validation and the test set. Thus we can think of our problem
as having a large graph where half of the graph is unlabeled and
our goal is to predict the labels based on the labels of the nodes in
the graph and the features of the node. With the transductive setup
in mind, we feed in the features of all nodes during training and
our goal is to predict the masked labels.
For the induction task, we randomly choose a healthy adult and a
MS patient each for the validation and test sets and the remaining 5
MS patients and 4 healthy adults for training. We construct separate
knn-graphs for the training, validation, and test sets just like before.
It is important to note that the testing graphs are completely unseen
during training. Table 1 gives a complete description of the datasets
used in various experiments.
Table 1: Characteristics of our single cell dataset
Task Train Dev Test
Inductive # Nodes 43866 9686 13033
# Edges 332398 73552 100715
# Features 22005 22005 22005
# Classes 2 2 2
# Graphs 1 1 1
Transductive # Nodes 54000 6000 6667
# Features 22005 22005 22005
# Classes 2 2 2
# Edges 5007093
2.1 Related work
Machine learning, and particularly deep learning have been widely
used in the medical domain to predict diseases but mostly us-
ing medical images or EHR data. Machine learning has also been
used on scRNA-seq data for data de-noising, batch correction, data
imputation to correct for sparse signal detection or dropout, un-
supervised clustering, cell-type prediction [1, 3, 24, 43] and low-
dimensional visualization of samples relevant to human health
[2, 43]. Recently, transfer learning (using an autoencoder) has been
used to extract new gene-gene interactions [47] and random walks
have been used to predict gene responses to drugs [20]. In the
biomedical domain GNNs have mostly been used for prediction of
protein-protein interactions [45] and gene-gene interactions[20, 56].
However, to the best of our knowledge, predicting diseases from
single-cell RNA seq data using state-of-the-art methods have not
been tried successfully.
3 ARCHITECTURE OF OUR MODEL
We use the Graph Attention Network by [45] and we follow the
exposition in [45]. In this section we describe our model in detail.
The building block of our network is the graph attention layer. The
input to our layer is a set of node features, h = {h1,h2, ...,hN },
where hi ∈ RF , N is the number of nodes, and F is the number
of features in each node. The layer produces a new set of node
features (of possibly different cardinality F ′) as its output, h′ =
{h′1,h′2, ....h′N } where h′i ∈ RF
′ .
We apply a linear transformation called the weight matrix,W ∈
RF
′×F to every node. The weight matrixW is initialized with Glorot
initialization [17]. Self-attention is then computed on the nodes, i.e.
a shared attention mechanism
a : RF
′ × RF ′ → R (1)
that computes attention coefficients
ei j = a(Whi ,Whj ) (2)
We treat these ei j ’s as importance scores of node jâĂŹs features
to that of node i . This is the main difference between a graph
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attention network and a graph convolution network [23]. Unlike
[23], different importance scores are given to different nodes in the
same neighborhood, which allows for greater adaptability of the
model to various complicated datasets like ours.
Furthermore, we normalize these ei j ’s across all choices of j,
where j lies in some neighborhood of i using the softmax function:
αi j = softmaxj (ei j ) =
exp(ei j )∑
k ∈Ni exp(eik )
(3)
whereNi is some neighborhood of the node i . In all our applications,
the graphs are the KNN graphs andNi is the first order k-neighbors
of the node i . Thus in practice, we only compute ei j (and thus αi j )
for all nodes j in the first-order neighborhood of the node i , instead
of all pairs of nodes i and j.
In our experiments, the attention mechanism a is a single-layer
feedforward neural network on which we apply the LeakyReLU
non-linearity. The normalized attention coefficients are then used
to compute a linear combination of the features corresponding to
them, to serve as the final output features for every node (after
applying a nonlinearity, σ ):
h′i = σ
( ∑
j ∈Ni
αi jWhj
)
. (4)
As is now common in attention based networks, we use multi-
head attention, similar to [44, 45]. In this case, each attention head
learns an unique set of attention weights independent of the other
heads in a given layer. Specifically, K independent attention mech-
anisms execute the transformation of Equation 4, and then their
features are concatenated, resulting in the following output feature
representation:
h′i =
K
l=1
σ
( ∑
j ∈Ni
α li jW
lhj
)
. (5)
where | | denotes the concatenation operation, α li j are normalized at-
tention coefficients computed by the l-th attention mechanism and
Wl is the corresponding input linear transformationâĂŹs weight
matrix. Note that, in the final output, each node will have KF ′ fea-
tures.
Finally, in the final (prediction) layer of the network, we first
employ averaging, and then apply the final nonlinearity (logistic
sigmoid for our classification problems). Thus the equation for the
final layer is:
h′i = σ
(
1
K
K∑
l=1
∑
j ∈Ni
α li jW
lhj
)
. (6)
We also use weight clipping to prevent the gradients from ex-
ploding. Table 2 shows all the hyperparameters in our models used
for the experiments. Our code is written in PyTorch and is publicly
available at https://github.com/vandijklab/scGAT.
Another reason of working with Graph Attention Networks is
it’s power of interpretability. It is easy to visualize the attention
heads, i.e. the attention scores between various nodes by a head in
any given layer. Due to memory issues, we implemented a sparse
version of the code of [45].
4 EXPERIMENTS
In this section we will explain in detail our experiments. We com-
pare our work with random forests, a multilayer perceptrons, Graph
Convolution Networks as introduced in [23], and a dummy estima-
tor. Table 3 gives complete details of our results for the following
tasks. All reported numbers are from the test sets. We also experi-
mented with changing the default hyperparameters like changing
the width and breadth of the model, the learning rate, optimizers,
losses, and the dropout rate. However the best results were obtained
by our default hyperparameters.
Generally all deep learning models are trained by stochastic
gradient descent which requires us to minibatch our graphs. To
breakdown a large graph for memory purposes and fast efficient
training, we follow the algorithm in [9] which is implemented in
PyTorch Geometric. For the inductive task, we break up our training
graph into 4000 roughly equal subgraphs and use a batch size of
256 graphs. The average number of nodes in each batch is 2741.
But we do not split the the test or the validation graphs. For the
transductive task, we break our graph as before in 4000 subgraphs
and use a batch size of 256 subgraphs. The average number of nodes
per subgraph in a batch is 4657.
Table 2: Default hyperparameters used in the experiments
Graph Attention Network Graph Convolution Network
Number of layers 2 2
Hidden_size 8 256
Attention Heads 8 N/A
Optimizer Adagrad Adagrad
clip_grad_norm 5 2
learning rate scheduler cosine_decay & 1st decay steps = 1000 cosine_decay & 1st decay steps = 1000
weight_decay .0005 .005
Batch size 256 256
Dropout .5 .4
Slope in LeakyRelu .2 .2
Training Epochs 1000 1000
Early stopping 100 100
4.1 Transductive learning
We use our single cell dataset and we follow the transductive learn-
ing setup as in [49]. The transductive setup implies that during
training the model has access to all the nodes’ feature vectors. The
predictive power of the model is then evaluated on the masked test
nodes and we use masked validation nodes for validation purposes.
Our main task is to predict if a cell is healthy or has MS. We ran
our GAT model 8 times.
Table 3: Experimental results
Task Model Accuracy
Random 51.8
Inductive MLP 56.7
Random Forest 58.5
Graph Convolutional Network 72.1
Graph Attention Network(our) 92.3 ± .7
Transductive Graph Convolutional Network 82.91
Graph Attention Network(our) 86 ± .3
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Figure 3: Predicted probabilities from induction task per cell. A) PHATE plot of the data colored by ground truth labels. B)
PHATE plot colored by the predictions of our graph attention model. C) Model prediction probability (Y-axis) for indicated
ground truth label (X-axis).
4.2 Inductive learning
For this task we again use our single cell dataset. We have 13 per-
sons’ blood and CSF data and out of them 6 of them have MS and
the rest are healthy. We randomly choose a blood and CSF data of a
healthy adult and a MS patient each for the validation and test sets
and the remaining 5 MS patients and 4 healthy adults for training.
We construct separate knn-graphs for the training, validation, and
the test sets. We ran our GAT model 16 times.
Figure 4 shows the loss of our model for the induction and the
transduction tasks.
Figure 4: Negative log-likelihood losses for training and val-
idation sets in the induction (left) and transduction (right)
tasks.
5 DISCUSSION OF OUR RESULTS
Encouraged by the predictive ability of our model in both trans-
ductive and inductive tasks, we take a deeper look at the attention
heads and attention weights at various layers of our model. In this
section, we will extract meaningful biological information from the
attention heads.
5.1 Finding interesting gene markers
We look atWTh where T stands for transpose andWh stands for
the learned weight matrix for head h in layer 1.Wh in our case is
an 8 × 22005 matrix where 8 is the size of the hidden dimension.
For each row i of eachWTh , we take the max of the absolute value
and we define
дhi = maxj (|wi j |) (7)
and then we pick the highest 10 дhi for each h. We can think of
these genes as the most important features the model learns to
discriminate between healthy and MS cells.
A heatmap of these features for themodel trained in the inductive
task is shown in figure 5. We are encouraged to find IL2RG as a
learned feature in discriminating between healthy and MS cells.
The interleukin-2 receptor (IL2R) is involved in a signaling pathway
that is essential for T cell function and genetic variants of IL-2R
are associated with various autoimmune disorders, including MS
[7, 18]. In addition, we are encouraged that the network gives
a high weight to CD19, a marker for B cells, since B cells are
targeted by therapeutics and is thought to contribute to MS by
secreting autoreactive antibodies that cause neuroinflammation
and demyelination [21]. Gene Ontology of the other identified
features revealed that 38 out of 58 mapped genes are involved in
the regulation of the hormone secretion while a number of other
genes in our list are involved in the regulation of the nerve cell
development. Lipid metabolism and nerve cell development are
critical to normal myelination, so alterations to these processes
may lead to a triggering of the autoimmune system and cause
inflammation related to development of MS pathologies [14, 42].
Thus it is encouraging to see that representations learned by
our model align with the medical knowledge. Given the paucity of
molecular markers that can characterize MS disease states, other
than genes identified through genome-wide association studies and
metabolites indicative of neurological degeneration, we presume
that our model and this novel list of gene features will guide further
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experimental work into the pathophysiology of MS [28]. Broadly,
this feature selection approach promises to reveal biomarkers of
MS disease pathologies, which may be used for more cost-effective
diagnostic testing than the single-cell technologies affords like
DNA microarray screening or measuring gene expression by flow
cytometry [14].
5.2 Finding cell types most prototypical of MS
In both the tasks, we computed the top 100 cells that have the high-
est predicted probability of being MS. These are the cells that are
strongly indicative of MS. We noted that all of these cells are from
patients’ CSF. In contrast, the 100 most prototypical healthy cells
are approximately evenly split between being sourced from blood
or CSF samples. This confirms the common medical hypothesis
that patients’ CSF has a higher degree of information relevant to
central nervous system inflammation than blood cell samples [31].
In addition, these observations support that single-cell technology
may supplement existing neuroinflammation diagnostic criteria
relying on detection of spinal fluid abnormalities [28, 31].
We assess the predicted probability of being MS, stratified by
cell type in figure 6A. Cells involved in innate immunity, such as
macrophages and natural-killer cells, have a relatively lower aver-
age predicted probability of being MS compared to cells involved in
adaptive immunity, such as B cells and T cells. This reflects the cur-
rent medical understanding of the immune system’s role in MS and
the key role that adaptive immunity plays in autoimmune disorders
and neuroinflammation more broadly [16, 28, 39]. This suggests
that our model is tuned to recapitulate biological knowledge.
We assess the predicted probability of being MS, stratified by
patient in figure 6B. MS is known to present in different forms
and the severity of the disease can vary across patients [30]. Our
model performs a node classification task, yielding the predicted
probability of being MS for every cell drawn from a single patient.
Thus, a single patient can have cells that are more prototypically
healthy than MS. The average predicted probability is as low as
0.23 for healthy patients and as high as 0.88 for MS patients in
the transduction task. Both the transduction and induction tasks
have models that achieve good discriminability between disease-
states, with a Pearson’s correlation coefficient of 0.76 and 0.82,
respectively.
5.3 Visualizing Attention heads
In this subsection, we will take a deeper look at the features that our
GAT model learned and visualize the latent space using [32] and
[48]. We can construct a matrix whose (i, j) entry is αi j as defined
by equation 3 for each head in the first layer. We can think of these
attention matrices as normalized adjacency matrix of a directed
graph (i.e. the stochastic matrix one obtains from normalizing the
adjacency matrix of a graph).
And we can feed it into PHATE (figure 7), allowing us to visualize
the new graphs that our model has learned. We can easily see that
head 4 and head 8 learn very different graphs. On the other hand,
we can look at the learned h′ as in equation 4 by each head in
each layer which we view as the new features or the latent space.
Just as before, we can feed these new features into a manifold
learning algorithm and can construct new KNN graphs (with 10
Figure 5: Heatmap showing the top 10 gene features for each
head colored by learned weights in the induction task and
clustered by gene.
neighbors) for visualization with UMAP, as shown in the figure 8
for a 64 dimensional feature space constructed by concatenating
the hidden units for each each head per node. Here we see that
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Figure 6: Predicted probabilities from transduction task for
MS class label stratified by cell type and individual patient.
Violin plot shows kernel density estimate and inner box plot
shows interquartile range and median. A) Probabilities of
havingMS predicted by ourmodel for each cell type. B) Prob-
abilities of having MS predicted by our model for each pa-
tient.
the learned latent space separates healthy and MS cells in the low-
dimensional embedding. This further supports that ourmodel learns
to discriminate between healthy and MS labels.
6 FUTUREWORK
We are excited by the improvements that a Graph Attention Net-
works bring to single cell analysis. We would like to continue this
direction further by incorporating in multidimensional edge level
features. Another direction of our research is to come up with new
semi/unsupervised ways of creating new graphs from single cell
data by completely bypassing PCA and KNN graphs. And then
we can apply the models in this paper along with the edge level
modifications to our new graphs.
We are going to scale up our work to a much larger dataset which
requires us not only to experiment with the depth and the breadth
of our model but also introduces new computational challenges
like fitting large graphs in memory and doing computations more
effectively.
One of the striking results we found that conforms to the medical
knowledge is that the CSF cells are strong indicators of MS, whereas
the blood cell are not very good indicators. However getting the
CSF data is an expensive and invasive process. We are in process of
acquiring only the blood samples of MS patients. Thus predicting
Figure 7: New low-dimensional embeddings learned by the
PHATE algorithm after inputting graphs learned by various
attention heads in our model for the induction task.
Figure 8: Visualization of the latent space learned by our
Graph Attention Model during the induction task. The
UMAP plot of the original graph (left) and the UMAP plot
of the latent space (right).
MS from only blood samples becomes an extremely difficult task.
To alleviate the problem, we would like to do transfer learning
from our model that is trained on both blood and CSF samples and
the train/test only on the new blood samples. We hope that the
transfer learning will achieve better results than an untrained graph
neural network.
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7 CONCLUSION
Multiple sclerosis (MS) is an unpredictable disease of the central
nervous system that disrupts the flow of information within the
brain, and between the brain and body. The molecular markers and
characteristics of MS are still actively studied and there remains
no single test for diagnosing MS. Single-cell sequencing has rev-
olutionized biological discovery, providing an in-depth picture of
cellular differences and the interactions between various cells in
their microenvironments. However, scRNA-seq has mostly been
used for basic sciences but not for clinical or diagnostic use due
to its cost and the complexity of the data. In this work we use a
graph attention model on single cell data to predict MS. The model
is trained on a cohort of seven MS patients and six healthy adults
(HA) from the blood and cerebral spinal fluid (CSF) of each patient.
We perform transductive and inductive tasks and we achieve 86 %
and 92 % accuracy in predicting MS beating other methods such
as graph convolutional networks, random forest and MLP. Further,
we use the learned graph attention model to get insight into the
signatures (transcriptomic and genetic features) and the cells that
are important for this prediction. Using the attention weights we
extracted a list of 100 genes and we were encouraged to find CD19
and IL2RG in that list. We envision that the feature selection ap-
proach to produce a minimal gene set can function as biomarkers
in a clinical setting. We also computed the top 100 cells that have
the highest predicted probability of being MS and all of these cells
came from the patients’ CSF. In contrast, the 100 most prototypical
healthy cells are approximately evenly split between being sourced
from blood or CSF samples. This confirms the common medical
hypothesis that patients’ CSF has a higher degree of information
relevant to central nervous system inflammation than blood cell
samples. Finally the graph attention model also allow us to infer
a new feature space for the cells that emphasizes the difference
between the two conditions which we visualize via PHATE and
UMAP. There has been more emphasis on the identification of deter-
minants of disease progression and on how individual information
can be used to personalize treatment and we hope that this graph
neural networks will play in important role in predicting disease
and in identifying key determinant of those diseases.
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